Janus Henderson Group PLC Boosts Stock Position in Halozyme Therapeutics, Inc. $HALO
MarketBeat
Janus Henderson Group PLC grew its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 42.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,233,658 shares of the biopharmaceutical company's s
NASDAQ:HALO